Published • loading... • Updated
The Dark Side of Asia’s ‘Miracle Diet’
Summary by Asia Sentinel
1 Articles
1 Articles
The Dark Side of Asia’s ‘Miracle Diet’
By: Tomoaki TakeiMultinational pharma giant Eli Lilly’s Mounjaro (tirzepatide), the dual GIP/GLP-1 receptor agonist, is at the center of a rapidly escalating public health storm in East Asia. While clinically approved as a life-saving treatment for Type 2 diabetes, the drug has been effectively deified on social media as the ultimate cosmetic weight-los…
·Hong Kong
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
